This company listing is no longer active
Guardion Health Sciences Balance Sheet Health
Financial Health criteria checks 6/6
Guardion Health Sciences has a total shareholder equity of $13.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.3M and $1.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$14.82m |
| Equity | US$13.75m |
| Total liabilities | US$1.55m |
| Total assets | US$15.30m |
Recent financial health updates
Recent updates
Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper
Sep 22
Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost
Jun 06Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Apr 10Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward
Feb 06Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues
Apr 17Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67M
Aug 11Guardion Health closes Activ Nutritional acquisition
Jun 02Guardion Health initiates GlaucoCetin glaucoma trial
May 03The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More
Jan 15Guardion Health names industry veteran Bret Scholtes as new president and CEO
Dec 28Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?
Nov 24
Financial Position Analysis
Short Term Liabilities: GHSI's short term assets ($15.3M) exceed its short term liabilities ($917.3K).
Long Term Liabilities: GHSI's short term assets ($15.3M) exceed its long term liabilities ($631.3K).
Debt to Equity History and Analysis
Debt Level: GHSI is debt free.
Reducing Debt: GHSI had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GHSI has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: GHSI has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 0.8% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/01 08:55 |
| End of Day Share Price | 2024/10/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guardion Health Sciences, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Anthony Vendetti | Maxim Group |